3Xiaomin Deng, Jingtao Lu, Lois D, et al. p38 Mitogen - Activated Protein Kinase - Dependent Tumor Necrosis Factor Converting Enzyme Is Important for Liver Injury in Hepatotoxic Interaction between Lipopolysaccharide and Ranitidine[ J]. THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008,1 (326) :144 - 152.
4James P, Luyendyk, Lois D, et al. Coagulation - Dependent Gene Expression and Liver Injuty in Rats Given Lipopolysaceharide with Ranitidine but Not with Famotidine [ J ]. THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006,2(317) :635 -643.
5Marina Azevedo Vethacke, Desiree Garten, Claudia Groll, et al. Specific Therapeutic Schemes of Omeprazole Affect the Orientation of Helicobacter pylori [ J ]. Antimicrobial Agents and Chemotherapy,2009,53:3511 - 3514.
6Hudson N, Taha AS, Russell RI, et al. Famotidine for healing and maintenance in nonsteroidal anti - inflammatory, drug associated gastroduodenal ulceration [ J ]. Gastroenterology, 1997,112 : 1817 - 1822.
7Pallab Maity, Samik Bindu, Vinay Choubey, et al. Lansoprazole Protects and Heals Gastric Mucosa from Non - steroidal Anti - inflammatory Drug (NSAID) - induced Gastropathy by Inhibiting Mitochondrial as Well as Fas - mediated Death Pathways with Concurrent Induction of Mucosal Cell Renewal[ J ]. JOURNAL OF BIOLOGICAL CHEMISTRY ,2008,21 ( 283 ) : 14 391 - 14 401.
8Philip M, Philip D, Yusong C, et al, Gastric acid control with esomeprazole, lansoprazol, omeprazole, pantoprazole and rabeprazole : a five-way crossover stuty [ J ]. Am J Gastroenterol, 2003,98 : 2616 - 2620,
9Hatlebakk JG, Katz PO, Kuob D, et al. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole40mg daily [ J ]. Aliment Pharmacol Thr, 1998,12 : 1235 - 1240.
